Abstracts/Posters
1. Langley S J, Murdoch R D, Compton C H, Masterson C M, Woodcock
A A. Lack of bronchodilatory effect of BRL 55834 (a selective potassium
channel activator) in asthmatic patients. Am J Respir Crit Care
Med 1996; 153 (4):A804.
2. Langley S J, Masterson C M, Batty E P, Woodcock A. Bronchodilator
response to salbutamol after chronic dosing with salmeterol. Am
J Respir Crit Care Med 1997; 155 (4):A345.
3. Langley S J, Svanberg C. A study assessing the efficacy of one
sodium cromoglycate capsule from Spinhaler vs Eclips in AMP challenge.
Allergy 1997; 37:188.
4. Langley S J, Woodcock. Salbutamol dose response after chronic
treatment with salmeterol. Eur Respir J 1997; 10 (suppl 25):2s.
5. Jones M, Langley S J. The role of saline as a baseline in histamine
challenges. Eur Respir J 1997; 10 (suppl 25):57s.
6. Simpson A, Custovic A, Adisesh A, Pipis S, Hallam C, Craven M,
Cain G, Langley S J, Faragher E B, Woodcock A. Exhaled nitric oxide
(eNO) in relation to sensitisation and exposure to indoor allergens
in asthmatics. American Academy of Allergy and Immunology meeting,
Washington February 1998.
7. Langley S J, Masterson C M, Batty E P, Jones M. The subjective
sensation of chest tightness during bronchodilation in asthmatics.
Am J Respir Crit Care Med 1998; 157/3):A920.
8. Langley S J, Masterson C M., Batty E P, Jones M, Sykes A, Bogolubov
M, Stahl E G, Woodcock A. Comparison of single doses of HFA 134A
propellant and CFC salbutamol in mild to moderate asthmatic patients.
Eur Respir J 1998; 12 (suppl 28):67s.
9. Villeran C, O'Neill S O, Helbling A, Van Noord J A, Lee T, Chuchalin
A G, Langley S J, Gunewardena K, Suskovic S, Laurenzi M, Jasan J,
Leff J A. Montelukast compared to Salmeterol in the treatment of
exercise-induced asthma (EIA). Eur Respir J 1998; 12 (suppl 28):361s.
10. Compton C, Cedar E, Nieman RB, Amit O, Langley S J, Sapene M.
Ariflo improves pulmonary function in patients with asthma: results
of a study in patients taking inhaled corticosteroids. Am J Respir
Crit Car Med 1999; 159/3:A624.
11. Jones M, Langley S J, Masterton C M, Batty E P. Correlation
of airways resistance measured using the interrupter technique (MicroRint)
with standard spirometry. Am J Respir Crit Car Med 1999; 159/3:A651.
12. Langley S J, Jones M, Williams A J, Batty E P. Assessment of
a hand held interrupter device (MicroRint) to measure bronchodilator
effects in adult asthmatics. Am J Respir Crit Car Med 1999; 159/3:A652
13. Langley S J, Masterson CM, Batty E P, Jones M. Assessment of
a hand held interrupter device (MicroRint) to measure bronchodilator
effects in healthy volunteers. Eur Respir J 1999; 13 (suppl ):71s.
14. Brutsche M H, Brutsche I C, Munavvar M, Langley S J, Masterson
C, Daley-Yates P T, Brown R, Woodcock A. Pharmacokinetics and systemic
effects of inhaled fluticasone propionate (FP) are different in
asthmatics (A) and normal volunteers. Eur Respir J 1999; 12 (suppl):
345s.
15. Compton C, Cedar E, Nieman RB, Amit O, Langley S J, Sapene M.
SB 207499 improves pulmonary function in patients with asthma receiving
inhaled corticosteroids. Eur Respir J 1999; 12 (suppl): 288s.
16. Langley S, Woodcock A, Jones S.W., Rice L. A placebo controlled
comparison of single doses of salmeterol and the combination bronchodilator
Combivent on lung function over 12 hours in patients with chronic
obstructive pulmonary disease (COPD). BMJ 1999; 54 (suppl 3),
A65
17. JC. Kips, BJ. O'Connor, SJ. Langley, A. Woodcock, HAM. Kerstjenens,
DS Postma, M. Danzig, F. Cuss, RA. Pauwels. Results of a Phase I
trial with SCH55700, A humanized anti-IL5 antibody, in severe persistent
asthma. Am J Respir Crit Car Med 2000; 16, 161:A505
18. P.T. Daley-Yates, J. Tournant, M.H. Brutsche, I. Carlen-Brutsche,
M. Munavar, S. Langley, C. Masterson, A.A. Woodcock. Pulmonary absorption
kinetics of fluticasone propionate (FP) in healthy subjects and
asthmatics. Am J Respir Crit Car Med 2000,; 16, 161:A774
19. A. Frew, S.J.Langley, E.Gooden. Therapeutic equivalence of inhaled
budesonide (100mg bd) delivered by either a new multi-dose dry powder
inhaler (Airmax™) or a conventional dry powder inhaler (Turbohaler®)
using airways reactivity to inhaled adenosine 5’-monophosphate
in asthmatic subjects. ERS, Florence, Aug 2000.
20. P.T. Daley-Yates, J. Tournant, M.H. Brutsche, I. Carlen-Brutsche,
M. Munavar, S. Langley, C. Masterson, A.A. Woodcock. Lung residence
time and absorption rate for inhaled fluticasone propionate (FP)
in healthy subjects and asthmatics. Eur Respir J 2000;16 (suppl
31): 279s.
21. SJ Langley, S Goldthorpe, A Woodcock, A Custovic. Effect of
atopy and exposure to indoor allergens on lung function and airway
reactivity in asthma. Am J Respir Crit Car Med 2001;163:5:A602
22. S Goldthorpe, SJ Langley, M Craven, A Simpson, A Custovic, A
Woodcock. Sensitisation and exposure to indoor allergens increases
exhaled nitric oxide in asthma. Am J Respir Crit Car Med 2001;163:5:A720
23. SJ Langley, S Goldthorpe, C Hallam, A Custovic, A Woodcock.
Exhaled nitric oxide, bronchial reactivity and pulmonary function
in asthma. Am J Respir Crit Car Med 2001;163:5:A421
24. SJ Langley, A Derham, J Holden, C Whale, D Mukherjee, P Hedgland,
A Woodcock. Comparison of efficacy of fluticasone HFC 134a metered
dose inhaler and fluticasone (dry powder) diskhaler. Am J Respir
Crit Car Med 2001;161:5:A441.
25. SD Singh, C Whale, A Hatton, N Houghton, N Raza, PT Daly-Yates,
AA Woodcock. Comparison of the pharmacokinetics of inhaled fluticasone
propionate in patients with chronic obstructive pulmonary disease
and healthy subjects. American Journal Of Respiratory & Critical
Care Medicine, April 2001:
26. K Wilson, SD Singh, AA Woodcock. An audit of the use of salbutamol
in mild asthmatics. American Journal Of Respiratory & Critical
Care Medicine, April 2001:
27. C Whale, SD Singh, AA Woodcock. The reproducibility of capsaicin
cough in healthy subjects. American Journal Of Respiratory &
Critical Care Medicine, April 2001:
28. SD Singh, A Hatton, C Sutton And AA Woodcock. Repeat tuberculin
testing at 1 week causes a booster effect in UK subjects. American
Journal Of Respiratory & Critical Care Medicine, April 2001.
29. C Whale, SD Singh, N Houghton, A Hatton, AA Woodcock. Salbutamol
induced changes in ventilation-perfusion and pulse in chronic obstructive
pulmonary disease. American Journal Of Respiratory & Critical
Care Medicine, April 2001:
30. J. F. Donohue, J. A. van Noord, S. J. Langley, A. Lee, S. Kesten,
L. J. Towse. Superior bronchodilation of once daily tiotropium compared
to twice daily salmeterol in patients with COPD. Eur Respir J
2001;18(suppl 33):26s
31. S. J. Langley, S. Goldthorpe, A. Custovic, A. A. Woodcock. Effect
of disease duration on pulmonary function in asthma. Eur Respir
J 2001;18(suppl 33):34s.
32. S. J. Langley, B. McDonnell, D. Allen, N. Wheeler, M. Briggs,
A. A. Woodcock. Effect of fine particle mass (FPM) on the bronchodilator
and bronchoprotective properties of salmeterol. Eur Respir J
2001;18(suppl 33):101s
33. S. J. Langley, S. Goldthorpe, A. Custovic, A. Woodcock. Allergen
exposure in non-dog and non-house dust mite sensitized atopic asthmatic
subjects; effect on bronchial reactivity. Eur Respir J 2001;18(suppl
33):482s.
34. D.J. Allen, K. Wilson, R. Bright-Thomas, B. McDonnell and S.D.
Singh. The Pharmacology of Leukotriene D4 Induced Inflammation in
Human Skin. British Pharmacology Journal, 2001.
35. S Langley, L Towse, S Kesten, PM Calverley. Heart rate and rhythm
analysis from holter monitoring in COPD patients receiving tiotropium.
Am J Respir Crit Car Med 2002;165:8:A592
36. C.E. Austin, S.T. Woolley, M. Christie, S. Langley, C. Taylor,
A. Young and C.A. Sargent.CXCR1 and CXCR2 expression on leukocytes
from normal and COPD patients. Am J Respir Crit Car Med 2002;165:8:A597.
37. Terry Woolley, Carol Weyman-Jones, Stephen Langley, Alan Young
and Carol Sargent Systemic levels of IL-1Ra and IL-s1r11 are modulated
in stable COPD patients. Am J Respir Crit Car Med 2002;165:8:A597
38. D Acerbi , P Daley Yates , G Poli , A Woodcock , S Langley.
Pharmacokinetics of a New CFC-free Metered Dose Inhaler of Beclomethasone
Dipropionate Following Multiple Dosing in AsthmaticPatients. Respiratory
Drug Delivery VIII, 2002, Vol 2, pp 395-398
39. A.A.Woodcock, I.D.Pavord, L.Rice and T.P.McCarthy. A comparison
of the anti-inflammatory and clinical effects of salmeterol/fluticasone
propionate combination (SFC) with fluticasone propionate (FP) plus
montelukast (M) in patients with mild to moderate asthma. ATS
2003
40. D.J. Allen, R.J. Bright-Thomas, B.M. McDonnell, A. Pankhania,
E.P. Batty, S.J. Langley, A. Rossetti and A. Woodcock. A single
centre open study into the safety of Pulvinal™, a new dry
powder beclomethasone dipropionate (BDP) inhaler in the treatment
of mild to severe asthmatics. ATS 2003
41. Stephen J Langley, Elizabeth P Batty, Catherine M Masterson,
Luca Cantini, and Ashley Woodcock. Comparison of single doses of
salbutamol delivered from a metered dose inhaler (MDI) and a novel
dry powder inhaler (DPI) in asthmatic patients. ATS 2003
42. C.M.Houghton, S.D.Singh and A.A Woodcock. Reproducibility of
Impulse Oscillometry, Plethysmography and Spirometry in Asthmatic
and Healthy Subjects. AmJRCCM ;2003: 167;7 A141.
43. C Houghton, SJ Langley, J Holden, SD Singh, A Rossetti, L Cantini,
A Woodcock. Comparison of Formoterol HFA-134a Modulite™, Foradil™
CFC and Foradil™ Aerolizer™ and placebo on the bronchoprotective
and bronchodilator effects in a double blind, double dummy, cross-over
study. asthma, volume 4, supplement 1, 2003, a38
44. DJ Allen, S Percy, SJ Langley, A Woodcock. Regular inhaled combination
therapy provides sustained improvement in lung function in asthmatic
adults. World Asthma Meeting, Bangkok, 2004
|
